AFA
ELV icon

Abacus FCF Advisors’s Elevance Health ELV Stock Holding History

Abacus FCF Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,315
Closed -$1.01M – 161
2023
Q3 		$1.01M Sell
2,315
-64
-3% -$29K 0.54% 66
2023
Q2 		$1.06M Buy
2,379
+100
+4% +$46.1K 0.53% 71
2023
Q1 		$1.05M Buy
2,279
+378
+20% +$180K 0.56% 72
2022
Q4 		$975K Buy
+1,901
New +$965K 0.64% 56
2016
Q2 		– Sell
-12,571
Closed -$1.75M – 106
2016
Q1 		$1.75M Sell
12,571
-3,636
-22% -$486K 1% 51
2015
Q4 		$2.26M Buy
16,207
+791
+5% +$109K 1.04% 37
2015
Q3 		$2.16M Buy
+15,416
New +$2.32M 1.11% 32
2015
Q1 		– Sell
-13,336
Closed -$1.68M – 107
2014
Q4 		$1.68M Buy
+13,336
New +$1.65M 1.03% 76

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Abacus FCF Advisors's ELV Position: Q4 2023 in Review

Abacus FCF Advisors sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 2,315 shares — an estimated $1.01M sold.

Abacus FCF Advisors first reported a position in ELV in Q4 2014 and held it in 8 quarters. The position peaked at $2.26M in Q4 2015. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Abacus FCF Advisors reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Abacus FCF Advisors sold 2,315 Elevance Health shares in Q4 2023, an estimated $1.01M.
  • Abacus FCF Advisors first reported a position in Elevance Health in Q4 2014 and held it in 8 quarters.
  • Abacus FCF Advisors's Elevance Health position peaked at $2.26M in Q4 2015.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Abacus FCF Advisors's 13F filing for Q4 2023, filed 4 Jan 2024.